Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Needham analyst Ami Fadia downgraded the rating for Biogen Inc. BIIB from Buy to Hold and maintained the price target of $270. Biogen shares closed at $159.99 on Friday. See how other analysts view this stock.
- Wolfe Research analyst Jacob Lacks downgraded the rating for Matson, Inc. MATX from Outperform to Peer Perform. Matson shares closed at $160.65 on Friday. See how other analysts view this stock.
- Barclays analyst Nicholas Campanella downgraded Pinnacle West Capital Corporation PNW from Overweight to Equal-Weight and lowered the price target from $93 to $91. Pinnacle West Capital shares closed at $91.88 on Friday. See how other analysts view this stock.
- Argus Research analyst John Eade downgraded the rating for Fortive Corporation FTV from Buy to Hold. Fortive shares closed at $74.82 on Friday. See how other analysts view this stock.
- Stifel analyst Nathan Jones downgraded Curtiss-Wright Corporation CW from Buy to Hold and maintained the price target of $370. Curtiss-Wright shares closed at $358.35 on Friday. See how other analysts view this stock.
Considering buying BIIB stock? Here’s what analysts think:
Read More:
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
